SEC Form 3 · accession 0000899243-18-020093
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark A Goldsmith
Director · 10% Owner
Period of report
Jul 18, 2018
Accepted (ET)
Jul 18, 2018 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 130,347 | D | ||
| Common Stock | holding | — | — | — | 12,716 | I | By The Goldsmith Children 2011 Irrevocable Education Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.55 | holding | — | — | — | — | Mar 10, 2021 | Common Stock | 27,250 | — | D |
| Stock Option (right to buy)F2 | $5.51 | holding | — | — | — | — | Sep 20, 2026 | Common Stock | 9,083 | — | D |
| Stock Option (right to buy)F3 | $7.60 | holding | — | — | — | — | Mar 7, 2028 | Common Stock | 18,166 | — | D |
Explanation of responses
- F1This option was granted on March 11, 2011 and is fully vested.
- F2This option was granted on September 21, 2016 and is scheduled to vest as to 25% of the shares underlying the option on the date of grant, with the remainder vesting in equal quarterly installments through September 21, 2020.
- F3This option was granted on March 8, 2018 and is scheduled to vest as to 50% of the shares underlying the option on the date of grant, with the remainder vesting in equal quarterly installments through March 8, 2021.
Remarks
Exhibit Index: 24.1 Power of Attorney